REPRINT OF POLISH TRANSLATION OF ARTICLE BY ACCORD INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN (IASP) - PAIN 154 (2013) 2691-2699 Migraine headaches and pain with neuropathic characteristics: Comorbid conditions in patients with multiple sclerosis
Journal Title: BÓL - Year 2014, Vol 15, Issue 2
Abstract
We conducted a postal survey to assess the prevalence and characteristics of neuropathic pain and migraine in a cohort of multiple sclerosis (MS) patients. Of the 1300 questionnaires sent, 673 could be used for statistical analysis. Among the respondents, the overall pain prevalence in the previous month was 79%, with 51% experiencing pain with neuropathic characteristics (NCs) and 46% migraine. MS patients with both migraine and NC pain (32% of the respondents) reported more severe pain and had lower health-related quality of life than MS patients with either migraine or NC pain. Pain intensity in MS patients with migraine was moderate (6.0±0.1). Migraine was mostly episodic, but headaches were occurring on P15 days per month in 15% of those with migraine. MS patients with migraine were younger and had shorter disease durations than those with NC pain. NC pain was most often located in the extremities, back and head, and was frequently described as tingling and pins-and-needles. The intensity of NC pain was low to moderate (4.9±0.1), but positively correlated with the number of painful body sites. Nonetheless, patients with NC pain were more disabled (with a higher Expanded Disability Status Scale and pain interference index) than patients with migraine. Migraine, but not NC pain, was associated with age, disease duration, relapsing-remitting course, and interferon-beta treatment. This suggests that NC pain and migraine are mediated by different mechanisms. Therefore, pain mechanisms that specifically operate in MS patients need to be characterized to design optimal treatments for these individuals.
Authors and Affiliations
Xavier Moisset, Lemlih Ouchchane, Nathalie Guy, Dimitri J. Bayle, Radhouane Dallel, Pierre Clavelou
Keywords
Related Articles
- EP ID EP69166
- DOI -
- Views 151
- Downloads 0
The report of the ‘Winter Cancer Pain School’, Liverpool, 4-7 November 2014
Zastosowanie oksykodonu/naloksonu w leczeniu bólu u chorego na nowotwór: opis przypadku
Mimo znaczącego postępu w diagnostyce i leczeniu chorób nowotworowych, ból u chorych na nowotwory pozostaje poważnym problemem klinicznym. Większość pacjentów z umiarkowanym lub silnym bólem przewlekłym wymaga zastosowan...
Zaparcie i poopioidowe zaburzenia funkcji jelit – wciąż wyzwaniem terapeutycznym
Zaparcie jak i inne objawy z przewodu pokarmowego są dużym problemem u pacjentów z chorobami przewlekłymi, szczególnie w opiece paliatywnej, gdzie w leczeniu objawowym często wybiera się opioidy. Poopioidowe zaburzenia f...
Neuromodulation in headache treatment - clinical use of peripheral nerves stimulation for patients with migraine headache.
Headaches are one of the most common disorders affected approximately 45% of the general population and have a considerable socioeconomic impact. It is known and described about two hundreds of different headaches. Most...
The effect of neuromodulation and continuous brachial plexus block for treatment of critical upper limb ischemia in the course of septic shock: a case report
Sepsis is a set of clinical symptoms and pathophysiological signs described as generalized inflammatory response provoked by infection. Septic shock is an effect of hypovolemia caused by inflammatory mediators. They prov...